Data suggest that remote patient monitoring may support outpatient step-up dosing of bispecific antibodies by enabling earlier CRS detection.
A remote therapeutic monitoring device with integrated care may reduce healthcare utilization among outpatients receiving parenteral antimicrobial therapy.
Remote patient monitoring can safely enable outpatient bispecific dosing for selected patients, but older or high-risk individuals may still require closer human oversight and structured support.
A commercial partnership between Topcon Healthcare and RemoniHealth is integrating the latter’s home-based ocular disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results